Tranexamic acid
Term · Oncology and biomedicine · MLC-T-ONC-017288
A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action.
| Identifier | MLC-T-ONC-017288 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | tranhexamic acid |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017288",
"term": "Tranexamic acid",
"field": "Oncology and biomedicine",
"definition": "A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action.",
"synonyms": [
"tranhexamic acid"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tranexamic-acid/"
}
Record 16,598 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.